Cite
Vazquez R, Breal C, Zalmai L, et al. Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis. Blood Cancer J. 2021;11(3):62doi: 10.1038/s41408-021-00448-w.
Vazquez, R., Breal, C., Zalmai, L., Friedrich, C., Almire, C., Contejean, A., Barreau, S., Grignano, E., Willems, L., Deau-Fischer, B., Franchi, P., Vignon, M., Decroocq, J., Birsen, R., Goldwirt, L., Kaltenbach, S., Couronne, L., Fontenay, M., Kosmider, O., Bouscary, D., & Chapuis, N. (2021). Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis. Blood cancer journal, 11(3), 62. https://doi.org/10.1038/s41408-021-00448-w
Vazquez, Romain, et al. "Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis." Blood cancer journal vol. 11,3 (2021): 62. doi: https://doi.org/10.1038/s41408-021-00448-w
Vazquez R, Breal C, Zalmai L, Friedrich C, Almire C, Contejean A, Barreau S, Grignano E, Willems L, Deau-Fischer B, Franchi P, Vignon M, Decroocq J, Birsen R, Goldwirt L, Kaltenbach S, Couronne L, Fontenay M, Kosmider O, Bouscary D, Chapuis N. Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis. Blood Cancer J. 2021 Mar 19;11(3):62. doi: 10.1038/s41408-021-00448-w. PMID: 33741892; PMCID: PMC7979724.
Copy
Download .nbib